Achieve Life Sciences (ACHV) Accumulated Depreciation (2012 - 2020)

Achieve Life Sciences (ACHV) has 9 years of Accumulated Depreciation data on file, last reported at $632000.0 in Q4 2020.

• Quarterly Accumulated Depreciation rose 5.33% year-over-year to $632000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $632000.0 (up 5.33% YoY) and the FY2020 annual result came in at $632000.0, up 5.33% from the prior year.
• Accumulated Depreciation advanced to $632000.0 in Q4 2020, from $600000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $1.4 million in Q4 2016 to a low of $600000.0 in Q4 2019.
• A 5-year average of $897200.0 and a median of $720000.0 in 2018 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2016 — Accumulated Depreciation grew 13.11% — and 2018, when it slumped 33.64%.
• Tracing ACHV's Accumulated Depreciation over 5 years: stood at $1.4 million in 2016, then retreated by 25.12% to $1.1 million in 2017, then tumbled by 33.64% to $720000.0 in 2018, then fell by 16.67% to $600000.0 in 2019, then increased by 5.33% to $632000.0 in 2020.
• The last three Accumulated Depreciation figures came in at $632000.0 (Q4 2020), $600000.0 (Q4 2019), and $720000.0 (Q4 2018), per Business Quant data.